WEEKLY MARKET DIGEST: NEW HIGHS IN STOCKS ON TRUMP PROMISE BUT STILL NOT ALL CLEAR WITHOUT A PULLBACK FIRST $GLD $QQQ $SLV $SPY $TBT $USO

   Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the

Read More

MEAD JOHNSON BUYOUT TALKS CONTINUE $MJN $RBGLY $DANOY $NSRGY $KHC

This post was just published on ZYX Buy Change Alert. MJN is long from $66.26.  It is trading at $84.25 as of this writing. MJN continues buyout talks with RBGLY.  The offer is reportedly worth $90 per share.  Other potential suitors are DANOY, NSRGY, and KHC.  From our last post , Profits

Read More

WEEKLY MARKET DIGEST: IMPORTANT INDICATOR OF THE FUTURE SHIFTS ON JOBS REPORT $DIA $GLD $QQQ $SLV $SPY $TBF $TBT $USO

   Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the

Read More

UPGRADING INDIA ON POSITIVE BUDGET $EPI

    This post was just published on ZYX Global Multi Asset Allocation Alert.   Unlike the United States, annual budget in India of the central government (equivalent of the federal government in the United States) is one of the most important events that influences the Indian stock market.   The budget just presented

Read More

MOMENTA PHARMACEUTICALS JUMPS ON COPAXONE RULING, TAKE PROFITS AND EXIT THE POSITION IF STILL HOLDING $MNTA $MYL $TEVA

This post was published on ZYX Buy Change Alert. MNTA has an average price of $11.31.  As of this writing it is trading at $19.05. The stock has jumped on a court invalidating TEVA patent on a MS drug Copaxone.  This was part of the original thesis to buy MNTA.  MYL is

Read More

MYLAN BENEFITING FROM COPAXONE $MYL $TEVA

This post was just published on ZYX Buy Change Alert. MYL is benefiting from invalidation of TEVA patent on Copaxone, an MS drug.  The new buy zone is $32 to $35.57.  Recommended position size is 35% to 40%.  The stock is trading at $38.40 as of this writing. What To Do Now

Read More

UPDATE ON RITE AID BUYOUT BY WALGREENS BOOTS $RAD $WBA $FRED

This post was just published on ZYX Buy Change Alert.  Totally contrary to its prior statements, WBA has reduced the buyout price for RAD from $9 per share to $7 per share if fewer than 1000 stores are required to be divested and to $6.50 if 1200 stores are required for divesture.  If

Read More

A NEW TRADE AROUND POSITION ON RITE AID $RAD $WBA $FRED

This post was just published on ZYX Buy Change Alert. This is a short-term trade, not an investment for aggressive traders as the risk of loss is high. Consider buying up to 20% of RAD in the zone of $6.00 to $6.70.  Stop zone is $5.38 to $5.73.  Target zone is $7.50

Read More

WEEKLY MARKET DIGEST: GROWTH COOLS, CUSP OF TRADE WAR, GOLD INVESTORS WATCH JAPANESE AND FRENCH BONDS $DIA $GLD $QQQ $SLV $SPY $TBF $TBT $USO

   Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the

Read More

NIGAM ARORA ON GOLD: IF TRUMP’S REMARKS CAUSE CURRENCY TURMOIL, GOLD WILL GO UP $GLD $SLV $NUGT $ABX $CDE $DUST $GDX $GDXJ $HMY $SLW

Here is the interview of Nigam Arora on gold by Business Standard, India’s second largest financial publication.  India is often the largest or the second largest consumer of gold.  Enjoy! Nigam Arora is a financial market expert forecasting market trends using algorithms. His famous ‘Arora report’ is widely followed. In

Read More

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

AI is power hungry. Investors will make a fortune from nuclear power for AI.

Get the list of 12 nuclear power stocks to grab your share of the profits.

Big Tech is investing billions

Making A Fortune
In Nuclear Energy

Golden Age of Nuclear Energy

Skip to content